top of page

POLTER

OPTIMIZATION OF BALIXAFORTIDE WITH NAB-PACLITAXEL OR ERIBULIN FOR HER2- ADVANCED BREAST CANCER

CLINICAL TRIAL DETAILS

OPTIMIZATION OF BALIXAFORTIDE WITH NAB-PACLITAXEL OR ERIBULIN FOR HER2- ADVANCED BREAST CANCER (POL6326 (BALIXAFORTIDE) PLUS NAB-PACLITAXEL OR ERIBULIN IN PATIENTS WITH HER2-NEGATIVE ADVANCED BREAST CANCER).

-

COUNTRY

STATUS

TUMOR TYPE

PHASE

N

SITES

BREAST

​

-

I, II

Spain

DRAFT

TRIAL OVERVIEW

home_fondo_you_barra.jpg
Luzern_edited_edited_edited_edited_edite

PRESS RELEASE

home_fondo_you_barra.jpg

-

SCIENTIFIC IMPACT

home_fondo_you_barra.jpg

-

BLOG ARTICLES RELATED

home_fondo_you_barra.jpg

-

TRIAL SITES

home_fondo_you_barra.jpg
-
Dr. Sofia Braga
Dr. Silvi Antolín
Dr. Escrivá de Romaní
Dr. Philipp Aftimos
Dr. Manuel Ruiz
Prof. Daniele Generali PHEGain interview
Dr. Jacques Medioni
Dr. Dunca Wheatley
bottom of page